Clinical Trial Update: Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With HB110E [NA]

View source ↗

Summary

This clinical trial update reports the completed study of an HBsAg vaccine in combination with standard antiviral therapy HB110E for chronic hepatitis B, focusi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HB110E (HB110E)
• HBsAg vaccine (HBsAg vaccine)

Snippet

Sponsor: Genexine, Inc. | Conditions: Chronic Hepatitis B | NA | Status: COMPLETED